INMODE LTD IS -01 Asset Resilience Ratio
INMODE LTD IS -01 asset resilience ratio. INMODE LTD IS -01 (154) has an Asset Resilience Ratio of 19.03% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 154 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of INMODE LTD IS -01 (2022–2025)
Asset resilience ratio of INMODE LTD IS -01 from 2022 to 2025. This chart shows how INMODE LTD IS -01's Asset Resilience Ratio has changed over time. Read 154 total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down INMODE LTD IS -01's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is INMODE LTD IS -01's balance sheet.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €142.86 Million | 19.03% |
| Total Liquid Assets | €142.86 Million | 19.03% |
Asset Resilience Insights
- Good Liquidity Position: INMODE LTD IS -01 maintains a healthy 19.03% of assets in liquid form.
- This level provides good financial flexibility while maintaining productive asset deployment.
- The company has significant short-term investments, indicating active treasury management.
INMODE LTD IS -01 Industry Peers by Asset Resilience Ratio
Compare INMODE LTD IS -01's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
T&L Co. Ltd
KQ:340570 |
Medical Devices | 26.03% |
|
Paxman AB
ST:PAX |
Medical Devices | -3.83% |
|
VIROMED MEDICAL NA O.N.
XETRA:VME |
Medical Devices | 0.03% |
|
Diagnostic Medical Systems SA
PA:ALDMS |
Medical Devices | 1.48% |
|
Pulsenmore Ltd
TA:PULS |
Medical Devices | 51.61% |
|
Geratherm Medical AG
XETRA:GME |
Medical Devices | 34.89% |
INMODE LTD IS -01 Asset Resilience Ratio by Year (2022–2025)
INMODE LTD IS -01 asset resilience ratio by year from 2022 to 2025. The table below shows the annual Asset Resilience Ratio data for INMODE LTD IS -01.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 32.98% | €252.79 Million ≈ $295.54 Million |
€766.43 Million ≈ $896.04 Million |
-23.17pp |
| 2024-12-31 | 56.15% | €441.14 Million ≈ $515.74 Million |
€785.67 Million ≈ $918.53 Million |
-13.03pp |
| 2023-12-31 | 69.18% | €597.19 Million ≈ $698.18 Million |
€863.29 Million ≈ $1.01 Billion |
-0.63pp |
| 2022-12-31 | 69.81% | €449.84 Million ≈ $525.91 Million |
€644.41 Million ≈ $753.38 Million |
-- |
About INMODE LTD IS -01
InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radio frequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States, Europe, Asia, and internationally. It offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous ski… Read more